The US Food and Drug Administration (FDA) has classified Vascular Solutions’ recently started voluntary nationwide recalling of Langston dual lumen catheters used in catheterisation procedures as a Class 1 recall.

The catheters are indicated for delivery of contrast medium in angiographic studies and for simultaneous pressure measurement from two sites.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Specific lots of the Langston dual lumen catheters were recalled on 23 May because of the potential for the inner catheter to separate from the hub during use and travel into a patient’s circulation.

This may require an intervention or surgery to retrieve the separated piece, the company said in a statement.

"Specific affected lots of Langston were of Model Numbers 5540 and 5550 were manufactured from January to April 2014."

In addition, the operator may be at increased risk of contact with contrast or bodily fluid, which could result in infection or injury.

See Also:

According to the company, specific affected lots of Langston were of Model Numbers 5540 and 5550 were manufactured from January to April 2014 and distributed from March to May.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Vascular Solutions said that a total of 8,580 of the catheters subject to the recall were sold, with around 3,847 still unused in the field.

So far, there have been two reports of the inner catheter entering the patient’s ventricle, requiring retrieval and no injuries have been reported.

Affected customers have been notified by the company by letter, following-up by phone call and in-person visit as necessary to ensure the return of all available affected products.

Until now, more than 86% of inventory has been accounted for and product is being returned to the company and the notification included instructions on how to return affected products.